Navigation Links
Positive Results Prompt US National Cancer Institute to Make,Gleevec Available To Patients in Post-Surgical Gist Study

strating a clinical benefit, such as improvement in disease-related symptoms or increased survival

Important Safety Information(1)

Severe (NCI Grades 3/4) lab abnormalities (400 mg/day; 600 mg/day)- including neutropenia (10%; 11%), anemia (3%; 9%), thrombocytopenia (0%; 1%), and hepatotoxicity (6%; 8%)-and severe adverse experiences (NCI Grades 3/4), including severe fluid retention (eg, pleural effusion or ascites; 3%; 8%) and superficial edema (6%; 5%), hemorrhage (6%; 11%), abdominal pain (11%; 4%), nausea (6%; 4%), diarrhea (3%; 7%), and musculoskeletal pain (6%; 1%) were reported among patients receiving Gleevec

Some patients (5%) were reported to have severe GI bleeds and/or intratumoral bleeds. GI tumor sites may have been the source of GI bleeds

Patients should be weighed and monitored regularly for signs and symptoms of edema, which can be serious or life-threatening. There have also been reports, including fatalities, of cardiac tamponade, cerebral edema, increased intracranial pressure, papilledema, and gastrointestinal (GI) perforation

Severe congestive heart failure and left ventricular dysfunction have occasionally been reported. Most of the patients with reported cardiac events have had other comorbidities and risk factors, including advanced age and previous medical history of cardiac disease. Patients with cardiac disease or risk factors for cardiac failure should be monitored carefully, and any patient with signs or symptoms consistent with cardiac failure should be evaluated and treated

Bullous dermatologic reactions (eg, erythema multiforme and Stevens- Johnson syndrome) have also been reported. In some cases, the reaction recurred upon rechallenge. Several postmarketing reports describe patients able to tolerate the reintroduction of Gleevec at a lower dose with or without concomitant corticosteroids or antihistamines following resolution or improvement of the bullous reaction

Dose adjustments ma
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
2. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Protox Announces Positive Clinical Data from Prostate Cancer Study
5. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
6. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
7. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
8. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis
Post Your Comments:
(Date:1/14/2014)... 14, 2014 InformEx, North America,s ... chemistry, will hold the 30 th edition of its ... Convention Center from January 21-24. (Logo: http://photos.prnewswire.com/prnh/20131028/NY05330LOGO-a ... pharmaceutical, fine chemical and specialty chemical companies will take part ...
(Date:1/14/2014)... Va. , Jan. 14, 2014 Animal Emergency Critical Care, ... Leesburg, Virginia is the first in ... oxygen chamber. Dr. Susan M. Barnes , ... Dr. Barnes and husband, Dr. Cole Taylor , are avid ...
(Date:1/14/2014)... PORT WASHINGTON, New York , January 14, ... the leading provider of Closed System Transfer Devices (CSTD) for hazardous drugs, ... sales growth for the fourth straight year.   ... of exposure for pharmacy technicians, pharmacists, nurses and ...
Breaking Medicine Technology:Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2Hyperbaric Veterinary Medicine (hvm) Announces Animal Emergency Critical Care Installs A Small Animal Hyperbaric Chamber 2Equashield's Sales Grow by 60% in 2013 2
(Date:4/23/2014)... Ill. - In a country as wealthy as the United ... 12 seniors do not have access to adequate food due ... food insecure. , Recent research at the University of ... Survey (NHANES) revealed that the seniors who are dealing with ... , "In 2011, 8.35 percent of Americans over age 60 ...
(Date:4/23/2014)... Parents and physicians concerned about an increase in adolescents, ... breathe a sigh of relief. According to a new ... worth of data from states with and without medical ... increased use among adolescents. The study is published online ... Adolescent Health . , "Any time a state ...
(Date:4/23/2014)... Ritalin, may prevent the depletion of self-control, according to ... of the Association for Psychological Science. , Self-control can ... to focus attention on a boring textbook are hard ... for this difficulty: Exerting self-control for a long period ... on subsequent tasks. , "It is as if self-control ...
(Date:4/22/2014)... is a popular high school sport in the United ... study by researchers in the Center for Injury Research ... to compare and describe the occurrence and distribution patterns ... high school athletic training setting among adolescents and teens. ... of Athletic Training , examined data relating to adolescents ...
(Date:4/22/2014)... last few decades researchers have characterized a set of ... behavior in all types of species, from flies to ... but researchers surmise there are more. A team from ... Pennsylvania wondered if big-data approaches could find them. ... John Hogenesch, PhD, professor of Pharmacology and first author ...
Breaking Medicine News(10 mins):Health News:More Americans in their golden years are going hungry 2Health News:RI Hospital physician: Legalizing medical marijuana doesn't increase use among adolescents 2Health News:ADHD drug may help preserve our self-control resources 2Health News:New study finds 2.5 million basketball injuries to high school athletes in 6 seasons 2Health News:New study finds 2.5 million basketball injuries to high school athletes in 6 seasons 3Health News:Bioinformatics profiling identifies a new mammalian clock gene 2
... , , , ... ), a medical device company that develops, manufactures and markets innovative proprietary ... fiscal quarter ended June 30, 2009. , , "Our ... the fiscal year of growing U.S. Macroplastique sales and accumulating the clinical ...
... 3 Cephalon, Inc. (Nasdaq: CEPH ) today ... published data from a pivotal phase 3 study demonstrating that ... to chlorambucil in patients with chronic lymphocytic leukemia (CLL). ... 2008 U.S. Food and Drug Administration (FDA) approval of TREANDA ...
... TV raises risk more than other low-level activities, such as ... -- Young children who spend too much time in front ... at increased risk for high blood pressure, a new study ... sedentary behavior and blood pressure in 111 boys and girls, ...
... , , , ... supports those in transition from group coverage to individual coverage , ... Blue Cross and Blue Shield Association (BCBSA) today announced the launch ... a wide range of healthcare options to find coverage that best fits ...
... , , MANHATTAN, Kan., Aug. 3 ... a K-State researcher are making headway in the effort to control ... is a Regents Distinguished Professor at K-State,s College of Veterinary Medicine ... K-State and with outside collaborators is revealing the characteristics of the ...
... ST. LOUIS, Aug. 3 , , ... recently completed its yearly survey of in-house physician recruiters on the ... that the physician shortage, coupled with the aging population, has taken ... openings. Survey results were compiled between May 1 and May ...
Cached Medicine News:Health News:Uroplasty Reports First Fiscal Quarter Results 2Health News:Uroplasty Reports First Fiscal Quarter Results 3Health News:Uroplasty Reports First Fiscal Quarter Results 4Health News:Uroplasty Reports First Fiscal Quarter Results 5Health News:Uroplasty Reports First Fiscal Quarter Results 6Health News:Uroplasty Reports First Fiscal Quarter Results 7Health News:Uroplasty Reports First Fiscal Quarter Results 8Health News:Uroplasty Reports First Fiscal Quarter Results 9Health News:Uroplasty Reports First Fiscal Quarter Results 10Health News:Uroplasty Reports First Fiscal Quarter Results 11Health News:Uroplasty Reports First Fiscal Quarter Results 12Health News:Uroplasty Reports First Fiscal Quarter Results 13Health News:Journal of Clinical Oncology Publishes TREANDA Study Demonstrating Significant Improvement in Overall Response and Progression-Free Survival in Chronic Lymphocytic Leukemia 2Health News:Journal of Clinical Oncology Publishes TREANDA Study Demonstrating Significant Improvement in Overall Response and Progression-Free Survival in Chronic Lymphocytic Leukemia 3Health News:Journal of Clinical Oncology Publishes TREANDA Study Demonstrating Significant Improvement in Overall Response and Progression-Free Survival in Chronic Lymphocytic Leukemia 4Health News:Journal of Clinical Oncology Publishes TREANDA Study Demonstrating Significant Improvement in Overall Response and Progression-Free Survival in Chronic Lymphocytic Leukemia 5Health News:Young Kids' Screen Time May Raise Blood Pressure 2Health News:Blue Cross and Blue Shield Association Introduces Interactive Navigation Solution That Helps Individuals and Families Find Healthcare Coverage Options 2Health News:K-State Researcher, Collaborators Study Virulence of Pandemic H1N1 Virus; Work at K-State Would Protect Pig Industry If the Virus Jumps to Swine Populations 2Health News:PracticeMatch Releases Results of Recent 'State of the Industry' Survey of Physician Recruiters 2
... iFacts™ is the handheld ... Facts, a drug interaction ... brand and generic drugs. ... to refer to accurate ...
... Completely revised and updated for ... up-to-date guide to all aspects of ... comprehensive, easy to use catalog of ... off label commonly used in cancer ...
Nursing2006 Drug Handbook Entries include Alerts, dosage adjustments for specific populations, I.V. administration, off-label indications, adverse reactions, and more....
... A to Z Drug Facts produced ... information on thousands of medications. It ... side effect, drug interactions, patient information ... drug reference for physicians, students, residents, ...
Medicine Products: